{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:38:36Z","timestamp":1790422716840,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1097\/iae.0b013e3181c596b1","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T06:28:00Z","timestamp":1269498480000},"page":"748-755","source":"Crossref","is-referenced-by-count":51,"title":["LONG-TERM OUTCOMES OF INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR THE MANAGEMENT OF CHOROIDAL NEOVASCULARIZATION IN PSEUDOXANTHOMA ELASTICUM"],"prefix":"10.1097","volume":"30","author":[{"given":"JANE S.","family":"MYUNG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PAWAN","family":"BHATNAGAR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RICHARD F.","family":"SPAIDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAMES M.","family":"KLANCNIK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHAEL J.","family":"COONEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LAWRENCE A.","family":"YANNUZZI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. BAILEY","family":"FREUND","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0039-6257(03)00053-5","article-title":"Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update.","volume":"48","author":"Hu","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"R2-6-20210130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/76102","article-title":"Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum.","volume":"25","author":"Le Saux","year":"2000","journal-title":"Nat Genet"},{"key":"R3-6-20210130","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1073\/pnas.100041297","article-title":"Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter.","volume":"97","author":"Ringpfeil","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"R4-6-20210130","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/jmg.2004.030171","article-title":"Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations.","volume":"42","author":"Chassaing","year":"2005","journal-title":"J Med Genet"},{"key":"R5-6-20210130","first-page":"118","article-title":"Angioid Streaks. Stereoscopic Atlas of Macular Diseases.","author":"Gass","year":"1997"},{"key":"R6-6-20210130","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00006982-200310000-00029","article-title":"Photo essay: \u2018comet\u2019 lesions: an ocular sign of pseudoxanthoma elasticum.","volume":"23","author":"Gass","year":"2003","journal-title":"Retina"},{"key":"R7-6-20210130","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archopht.123.7.923","article-title":"Spectrum of pattern dystrophy in pseudoxanthoma elasticum.","volume":"123","author":"Agarwal","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R8-6-20210130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0039-6257(82)90158-8","article-title":"Angioid streaks.","volume":"26","author":"Clarkson","year":"1982","journal-title":"Surv Ophthalmol"},{"key":"R9-6-20210130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bjo.59.5.257","article-title":"Angioid streaks. I. Ophthalmoscopic variations and diagnostic problems.","volume":"59","author":"Shields","year":"1975","journal-title":"Br J Ophthalmol"},{"key":"R10-6-20210130","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0002-9343(61)90078-X","article-title":"Pseudoxanthoma elasticum and angioid streaks: a review of 106 cases.","volume":"30","author":"Conner","year":"1961","journal-title":"Am J Med"},{"key":"R11-6-20210130","first-page":"136","article-title":"Management of Retinal Vascular and Macular Disorders.","author":"Piro","year":"1983"},{"key":"R12-6-20210130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000309793","article-title":"Laser treatment of macular subretinal neovascularization in angioid streaks.","volume":"195","author":"Brancato","year":"1978","journal-title":"Ophthalmologica"},{"key":"R13-6-20210130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9394(88)90014-1","article-title":"A long-term follow-up study of laser coagulation of neovascular membranes in angioid streaks.","volume":"105","author":"Geliksen","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"R14-6-20210130","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0002-9394(14)71398-4","article-title":"Laser treatment of choroidal neovascularization in patients with angioid streaks.","volume":"116","author":"Lim","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"R15-6-20210130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0002-9394(02)01626-4","article-title":"Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks.","volume":"143","author":"Karacorlu","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R16-6-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(02)01835-4","article-title":"Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks.","volume":"135","author":"Shaikh","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R17-6-20210130","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ophtha.2005.02.011","article-title":"Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.","volume":"112","author":"Browning","year":"2005","journal-title":"Ophthalmology"},{"key":"R18-6-20210130","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0002-9394(00)00809-6","article-title":"Macular translocation for subfoveal choroidal neovascularization in angioid streaks.","volume":"131","author":"Roth","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R19-6-20210130","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/IAE.0b013e31809ff5df","article-title":"Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum.","volume":"27","author":"Bhatnagar","year":"2007","journal-title":"Retina"},{"key":"R20-6-20210130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00347-006-1456-y","article-title":"Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks [in German].","volume":"104","author":"Lommatzsch","year":"2007","journal-title":"Ophthalmologe"},{"key":"R21-6-20210130","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1590\/S0004-27492008000300024","article-title":"Intravitreal bevacizumab in choroidal neovascularization secondary to Gr\u00f6nblad-Strandberg syndrome: case report.","volume":"71","author":"Japiass\u00fa","year":"2008","journal-title":"Arq Bras Oftalmol"},{"key":"R22-6-20210130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/bjo.2007.129916","article-title":"Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum.","volume":"92","author":"Finger","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R23-6-20210130","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1755-3768.2007.00895.x","article-title":"Treatment of choroidal neovascularization using intravitreal bevacizumab.","volume":"85","author":"Pedersen","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"R24-6-20210130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1600-0420.2006.00762.x","article-title":"Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.","volume":"84","author":"Teixeira","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"R25-6-20210130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4103\/0301-4738.36482","article-title":"Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks.","volume":"55","author":"Sachdev","year":"2007","journal-title":"Indian J Ophthalmol"},{"key":"R26-6-20210130","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1001\/archopht.125.10.1422","article-title":"Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks.","volume":"125","author":"Rinaldi","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R27-6-20210130","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00006982-200410000-00013","article-title":"Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy.","volume":"24","author":"Menchini","year":"2004","journal-title":"Retina"},{"key":"R28-6-20210130","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00417-005-1193-y","article-title":"Photodynamic therapy with verteporfin for choroidal neovascularization associated with angioid streaks.","volume":"243","author":"Heimann","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R29-6-20210130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000093071","article-title":"Photodynamic therapy using verteporfin for choroidal neovascularization associated with angioid streaks\u2014long-term effects.","volume":"38","author":"Jurklies","year":"2006","journal-title":"Ophthalmic Res"},{"key":"R30-6-20210130","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.ophtha.2007.03.057","article-title":"Photodynamic therapy for angioid streaks.","volume":"114","author":"Browning","year":"2007","journal-title":"Ophthalmology"},{"key":"R31-6-20210130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00006982-198101020-00001","article-title":"Laser treatment of choroidal neovascular membranes in angioid streaks.","volume":"1","author":"Singerman","year":"1981","journal-title":"Retina"},{"key":"R32-6-20210130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00006982-199701000-00003","article-title":"Laser photocoagulation of choroidal neovascularization in angioid streaks.","volume":"17","author":"Pece","year":"1997","journal-title":"Retina"},{"key":"R33-6-20210130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R34-6-20210130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.iae.0000238561.99283.0e","article-title":"Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.","volume":"26","author":"Spaide","year":"2006","journal-title":"Retina"},{"key":"R35-6-20210130","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration.","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"R36-6-20210130","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/01.iae.0000240121.28034.c3","article-title":"Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab.","volume":"26","author":"Laud","year":"2006","journal-title":"Retina"},{"key":"R37-6-20210130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"R38-6-20210130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/bjo.2007.130260","article-title":"Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results.","volume":"92","author":"Arias","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R39-6-20210130","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archopht.126.7.941","article-title":"Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration.","volume":"126","author":"Chang","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R40-6-20210130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/IAE.0b013e318187aff9","article-title":"Bevacizumab (Avastin) and ranibizumab (Lucentis) for choroidal neovascularization in multifocal choroiditis.","volume":"29","author":"Fine","year":"2009","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0b013e3181c596b1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:42:52Z","timestamp":1620956572000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201005000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181c596b1","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}